Light Mode
$11.55 ↓ -0.05 (-0.45%) Trading Down from the previous close of $11.60, and at the day’s high of $11.55
+0.47 (+4.25%) / 6M
Momentum, market sentiment, and recent alerts
IVBXF reads n/a: price sits above one of the two key moving averages, the 12-month move is +1.3%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. It operates through the following geographical segments: The People's Republic of China (PRC), the United States of America (USA), and Indonesia. The company was founded by De Chao Yu, Kevin Chen, and Scott M. Wheelwright on April 28, 2011 and is headquartered in Suzhou, China.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.